Data provided by Kaleidoscope.
| Filing date | Form | Description | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
Crinetics Pharmaceuticals, Inc. | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
Quarterly Filings
|
Crinetics Pharmaceuticals, Inc. | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
Crinetics Pharmaceuticals, Inc. | EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
Crinetics Pharmaceuticals, Inc. | View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
Crinetics Pharmaceuticals, Inc. | View HTML | |
| 3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
Crinetics Pharmaceuticals, Inc. | View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
Crinetics Pharmaceuticals, Inc. | View HTML | |
| 8-K | Report of unscheduled material events or corporate event |
Current Reports
|
Crinetics Pharmaceuticals, Inc. | View HTML | |
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
Quarterly Filings
|
Crinetics Pharmaceuticals, Inc. | EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
3,4,5
|
Crinetics Pharmaceuticals, Inc. | View HTML |
Data provided by Kaleidoscope.